208 related articles for article (PubMed ID: 24354316)
1. Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis.
Tatipaka HB; Gillespie JR; Chatterjee AK; Norcross NR; Hulverson MA; Ranade RM; Nagendar P; Creason SA; McQueen J; Duster NA; Nagle A; Supek F; Molteni V; Wenzler T; Brun R; Glynne R; Buckner FS; Gelb MH
J Med Chem; 2014 Feb; 57(3):828-35. PubMed ID: 24354316
[TBL] [Abstract][Full Text] [Related]
2. Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei.
Ferrins L; Gazdik M; Rahmani R; Varghese S; Sykes ML; Jones AJ; Avery VM; White KL; Ryan E; Charman SA; Kaiser M; Bergström CA; Baell JB
J Med Chem; 2014 Aug; 57(15):6393-402. PubMed ID: 24978605
[TBL] [Abstract][Full Text] [Related]
3. Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitors.
Buchynskyy A; Gillespie JR; Hulverson MA; McQueen J; Creason SA; Ranade RM; Duster NA; Gelb MH; Buckner FS
Bioorg Med Chem; 2017 Mar; 25(5):1571-1584. PubMed ID: 28187957
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
[TBL] [Abstract][Full Text] [Related]
5. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
[TBL] [Abstract][Full Text] [Related]
6. Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis.
Barker RH; Liu H; Hirth B; Celatka CA; Fitzpatrick R; Xiang Y; Willert EK; Phillips MA; Kaiser M; Bacchi CJ; Rodriguez A; Yarlett N; Klinger JD; Sybertz E
Antimicrob Agents Chemother; 2009 May; 53(5):2052-8. PubMed ID: 19289530
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis.
Vodnala SK; Lundbäck T; Yeheskieli E; Sjöberg B; Gustavsson AL; Svensson R; Olivera GC; Eze AA; de Koning HP; Hammarström LG; Rottenberg ME
J Med Chem; 2013 Dec; 56(24):9861-73. PubMed ID: 24283924
[TBL] [Abstract][Full Text] [Related]
8. Compounds containing 2-substituted imidazole ring for treatment against human African trypanosomiasis.
Samant BS; Sukhthankar MG
Bioorg Med Chem Lett; 2011 Feb; 21(3):1015-8. PubMed ID: 21211967
[TBL] [Abstract][Full Text] [Related]
9. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
10. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Jones AJ; Kaiser M; Avery VM
Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
[TBL] [Abstract][Full Text] [Related]
11. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
Bland ND; Wang C; Tallman C; Gustafson AE; Wang Z; Ashton TD; Ochiana SO; McAllister G; Cotter K; Fang AP; Gechijian L; Garceau N; Gangurde R; Ortenberg R; Ondrechen MJ; Campbell RK; Pollastri MP
J Med Chem; 2011 Dec; 54(23):8188-94. PubMed ID: 22023548
[TBL] [Abstract][Full Text] [Related]
13. Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter.
Gilbert IH
Parasitology; 2014 Jan; 141(1):28-36. PubMed ID: 23931634
[TBL] [Abstract][Full Text] [Related]
14. Trypanocidal activity of 8-methyl-5'-{[(Z)-4-aminobut-2-enyl]-(methylamino)}adenosine (Genz-644131), an adenosylmethionine decarboxylase inhibitor.
Bacchi CJ; Barker RH; Rodriguez A; Hirth B; Rattendi D; Yarlett N; Hendrick CL; Sybertz E
Antimicrob Agents Chemother; 2009 Aug; 53(8):3269-72. PubMed ID: 19451291
[TBL] [Abstract][Full Text] [Related]
15. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Structure-Activity Relationships of Imidazopyridine/Pyrimidine- and Furopyridine-Based Anti-infective Agents against Trypanosomiases.
Silva DG; Junker A; de Melo SMG; Fumagalli F; Gillespie JR; Molasky N; Buckner FS; Matheeussen A; Caljon G; Maes L; Emery FS
ChemMedChem; 2021 Mar; 16(6):966-975. PubMed ID: 33078573
[TBL] [Abstract][Full Text] [Related]
17. Trypanocidal activity of dicationic compounds related to pentamidine.
Donkor IO; Assefa H; Rattendi D; Lane S; Vargas M; Goldberg B; Bacchi C
Eur J Med Chem; 2001 Jun; 36(6):531-8. PubMed ID: 11525843
[TBL] [Abstract][Full Text] [Related]
18. Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties.
Fersing C; Boudot C; Paoli-Lombardo R; Primas N; Pinault E; Hutter S; Castera-Ducros C; Kabri Y; Pedron J; Bourgeade-Delmas S; Sournia-Saquet A; Stigliani JL; Valentin A; Azqueta A; Muruzabal D; Destere A; Wyllie S; Fairlamb AH; Corvaisier S; Since M; Malzert-Fréon A; Di Giorgio C; Rathelot P; Azas N; Courtioux B; Vanelle P; Verhaeghe P
Eur J Med Chem; 2020 Nov; 206():112668. PubMed ID: 32795774
[TBL] [Abstract][Full Text] [Related]
19. Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness.
Kaiser M; Bray MA; Cal M; Bourdin Trunz B; Torreele E; Brun R
Antimicrob Agents Chemother; 2011 Dec; 55(12):5602-8. PubMed ID: 21911566
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis.
Nare B; Wring S; Bacchi C; Beaudet B; Bowling T; Brun R; Chen D; Ding C; Freund Y; Gaukel E; Hussain A; Jarnagin K; Jenks M; Kaiser M; Mercer L; Mejia E; Noe A; Orr M; Parham R; Plattner J; Randolph R; Rattendi D; Rewerts C; Sligar J; Yarlett N; Don R; Jacobs R
Antimicrob Agents Chemother; 2010 Oct; 54(10):4379-88. PubMed ID: 20660666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
